H Lundbeck A/S - Asset Resilience Ratio

Latest as of December 2023: -0.56%

H Lundbeck A/S (HLUN-B) has an Asset Resilience Ratio of -0.56% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Dkr-208.00 Million

≈ $-32.54 Million USD Cash + Short-term Investments

Total Assets

Dkr37.41 Billion

≈ $5.85 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2022)

This chart shows how H Lundbeck A/S's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down H Lundbeck A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Dkr0.00	0%
Short-term Investments	Dkr-208.00 Million	-0.56%
Total Liquid Assets	Dkr-208.00 Million	-0.56%

Asset Resilience Insights

Limited Liquidity: H Lundbeck A/S maintains only -0.56% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

H Lundbeck A/S Industry Peers by Asset Resilience Ratio

Compare H Lundbeck A/S's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Painreform Ltd NASDAQ:PRFX	Drug Manufacturers - Specialty & Generic	0.00%
Incannex Healthcare Ltd ADR NASDAQ:IXHL	Drug Manufacturers - Specialty & Generic	0.06%
Zhejiang Nhu Co Ltd SHE:002001	Drug Manufacturers - Specialty & Generic	4.38%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Tianjin Zhongxin Pharmaceutical Group Corp Ltd SHG:600329	Drug Manufacturers - Specialty & Generic	5.92%

Annual Asset Resilience Ratio for H Lundbeck A/S (2008–2022)

The table below shows the annual Asset Resilience Ratio data for H Lundbeck A/S.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	-0.52%	Dkr-195.00 Million ≈ $-30.51 Million	Dkr37.45 Billion ≈ $5.86 Billion	-0.13pp
2021-12-31	-0.39%	Dkr-134.00 Million ≈ $-20.97 Million	Dkr34.65 Billion ≈ $5.42 Billion	-0.10pp
2020-12-31	-0.29%	Dkr-104.00 Million ≈ $-16.27 Million	Dkr36.03 Billion ≈ $5.64 Billion	-0.30pp
2019-12-31	0.01%	Dkr4.00 Million ≈ $625.83K	Dkr35.76 Billion ≈ $5.59 Billion	-13.16pp
2018-12-31	13.17%	Dkr3.03 Billion ≈ $474.07 Million	Dkr23.01 Billion ≈ $3.60 Billion	+5.46pp
2017-12-31	7.70%	Dkr1.52 Billion ≈ $238.13 Million	Dkr19.76 Billion ≈ $3.09 Billion	+7.62pp
2016-12-31	0.08%	Dkr17.00 Million ≈ $2.66 Million	Dkr20.21 Billion ≈ $3.16 Billion	+0.00pp
2015-12-31	0.08%	Dkr17.00 Million ≈ $2.66 Million	Dkr21.32 Billion ≈ $3.34 Billion	+0.01pp
2014-12-31	0.07%	Dkr18.00 Million ≈ $2.82 Million	Dkr25.64 Billion ≈ $4.01 Billion	-4.34pp
2013-12-31	4.41%	Dkr1.04 Billion ≈ $163.03 Million	Dkr23.65 Billion ≈ $3.70 Billion	-0.49pp
2012-12-31	4.89%	Dkr1.05 Billion ≈ $165.06 Million	Dkr21.56 Billion ≈ $3.37 Billion	-2.30pp
2011-12-31	7.19%	Dkr1.48 Billion ≈ $230.93 Million	Dkr20.53 Billion ≈ $3.21 Billion	+6.89pp
2010-12-31	0.30%	Dkr54.00 Million ≈ $8.45 Million	Dkr18.00 Billion ≈ $2.82 Billion	-0.04pp
2009-12-31	0.34%	Dkr59.00 Million ≈ $9.23 Million	Dkr17.13 Billion ≈ $2.68 Billion	-7.23pp
2008-12-31	7.58%	Dkr955.00 Million ≈ $149.42 Million	Dkr12.61 Billion ≈ $1.97 Billion	--

pp = percentage points

About H Lundbeck A/S

CO:HLUN-B Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$5.50 Billion

Dkr35.14 Billion DKK

Market Cap Rank

#3356 Global

#21 in Denmark

Share Price

Dkr44.30

Change (1 day)

+2.50%

52-Week Range

Dkr29.64 - Dkr47.34

All Time High

Dkr90.49